The short answer is that I don't have that information in front of me, so I'll have to get back to you on that.
Our interest in the pharmacare program is that there are different policies amongst the provinces. There's no continuity province to province on what drugs are covered and what drugs are not. We'd look for some conciliation between all of that. We also want to ensure that there are some bulk purchasing priorities that can be done, so that if all the provinces are buying together, they're going to get a much better cost per unit of that drug. That's our concern. We want to be able to level the playing field so that people in British Columbia are not getting a drug that a person in New Brunswick cannot get.
I can get those particulars back to you.